Robertet is the first major manufacturer to take make the leap into CBD in France. The leading aroma and flavor manufacturer has been interested in CDB for years, but has been unable to manufacture it in France until the passage of a recent decree legalizing it in the country. The company notes, however, that the cost price will be higher in France than for CBD from other regions.
Robertet, a world-leading manufacturer of aromas, perfumes, and active ingredients derived from natural raw materials, is the first major manufacturer to take the plunge into CBD France. Taking advantage of the decree of December 30, 2021, which authorizes French hemp growers to harvest hemp flowers and extractors to produce the famous CBD, an active ingredient with virtues presented as soothing, Robertet is starting its first production of cannabidiol made in France this week.
For more news about the evolution of the post-legalization CBD market in France, and other updates from around the world, download our free cannabis news app.
Recently, nearly a ton of raw material arrived at Robertet from the Grand Est region. It is, of course, limited as required by law to 0.3% THC, the psychotropic substance, and will be stored in warehouses in Robertet’s Grasse (Alpes-Maritimes) warehouses. “We should be able to produce, with such a quantity, between 20 and 30 kg of pure CBD”, said Olivier Maubert, who heads the food flavorings and well-being, health, and beauty active ingredients activities of Robertet.
For five years now, Robertet, which has a turnover of 600 million euros, has been interested in this promising active ingredient for its customers in the cosmetics or food industries looking for new products. Extraction activities have already been launched in the United States and Switzerland with local partners. Robertet has also filed a case with the European authorities under the “Novel Food” regulations, a prerequisite for the eventual use of CBD in food.
The company has also embarked on lobbying and co-founded the Union of Industrialists for the Valorization of Hemp Extracts (Uivec), which seeks to structure a French CBD production sector.
“France is the leading hemp producer in Europe, there is a real industrial logic in promoting a sector which, in addition, is sustainable”, notes Robertet’s Olivier Maubert, extolling the merits of this “miraculous” plant which does not need water or inputs and fertilizes the land.” It does not find more favorable conditions than at the level of the 45th parallel.
The cost price of CBD made in France will be higher than products currently imported from the United States and Eastern Europe, due in particular to a lower CBD level. But Robertet’s customers want a local product.
For now, many manufacturers are still reluctant to take the plunge because of legal uncertainties. To overcome this reluctance, Robertet created last year with associates a start-up called “Wailer,” which has just released a relaxing cream for athletes based on CBD. For the moment, Robertet only markets it on the Internet and in a few specialized stores. Importantly, this product will serve as a “proof of concept” in the eyes of cosmetics manufacturers.
__
(Featured image by Kindel Media via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published by Les Echos, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…
Denmark plans to make its pilot medical cannabis program permanent following its success in treating…
Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…
The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…
A new study involving over 23,000 participants in New Zealand found that 60% of people…
The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…